Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension

Clinical Endocrinology

Volumn 71, Issue 3, 2009, Pages 434-439

  Haymart, Megan R ^a   Glinberg, Simone L ^b   Liu, Jing ^b   Sippel, Rebecca S ^b   Jaume, Juan C ^b,c   Chen, Herbert ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HASHIMOTO DISEASE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; THYROID CANCER; THYROID SURGERY; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; THYROTROPIN; YOUNG ADULT;

EID: 68949212088     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03489.x     Document Type: Article

References (32)

1. Haymart, M.R., Repplinger, D.J., Leverson, G.E. et al. (2008) Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumour stage. Journal of Clinical Endocrinology and Metabolism, 93, 809 814.
2. Boelaert, K., Horacek, J., Holder, R.L. et al. (2006) Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. Journal of Clinical Endocrinology and Metabolism, 91, 4295 4301.
3. Dean, D.S. Hay, I.D. (2000) Prognostic indicators in differentiated thyroid carcinoma. Cancer Control: Journal of the Moffitt Cancer Center, 7, 229 238.
4. No authors listed (2002) Thyroid. In: F.L. Greene, D.L. Page, I.D. Fleming, A. Fritz, C.M. Balch, D.G. Haller, M. Morrow eds. AJCC Cancer Staging Manual, 6th edn. Springer-Verlag, New York, 77 87.
5. Gilliland, F.D., Hunt, W.C., Morris, D.M. et al. (1997) Prognostic factors for thyroid carcinoma: a population-based study of 15 698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer, 79, 564 573.
6. Jung, T.S., Kim, T.Y., Kim, K.W. et al. (2007) Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. Endocrine Journal, 54, 265 274.
7. Sampson, E., Brierley, J.D., Le, L.W. et al. (2007) Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer, 110, 1451 1456.
8. Lin, J.D., Liou, M.J., Chao, T.C. et al. (1999) Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases. Endocrine-Related Cancer, 6, 109 115.
9. Hundahl, S.A., Fleming, I.D., Fremgen, A.M. et al. (1998) A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer, 83, 2638 2648.
10. Surks, M.I. Hollowell, J.G. (2007) Age-specific distribution of serum TSH and antithyroid antibodies in the united states population: implications for the prevalence of subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism, 92, 4575 4582.
11. Hollowell, J.G., Staehling, N.W., Flanders, W.D. et al. (2002) Serum TSH, T4, and thyroid antibodies in the United States population (1988-1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism, 87, 489 499.
12. Miccoli, P., Minuto, M.N., Ugolini, C. et al. (2008) Papillary thyroid cancer: pathological parameters as prognostic factors in different classes of age. Journal of Otolaryngology - Head and Neck Surgery, 138, 200 203.
13. Mazzaferri, E.L. Kloos, R.T. (2001) Current approaches to primary therapy for papillary and follicular thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 86, 1447 1463.
14. Davies, L. Welch, H.G. (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association, 295, 2164 2167.
15. Tan, G.H. Gharib, H. (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Annals of Internal Medicine, 126, 226 231.
16. Anderson, S., Pederson, K.M., Bruun, N.H. et al. (2002) Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. Journal of Clinical Endocrinology and Metabolism, 87, 1068 1072.
17. Panicker, V., Wilson, S.G., Spector, T.D. et al. (2008) Heritability of serum TSH, free T4 and free T3 concentrations: a study of a large UK twin cohort. Clinical Endocrinology, 66, 652 659.
18. Panicker, V., Wilson, S.G., Spector, T.D. et al. (2008) Genetic loci linked to pituitary-thyroid axis set points: a genome-wide scan of a large twin cohort. Journal of Clinical Endocrinology and Metabolism, 93, 3519 3523.
19. Hansen, P.S., van der Deure, W.M., Peeters, R.P. et al. (2007) The impact of a TSH receptor gene polymorphism on thyroid related phenotypes in a healthy Danish twin population. Clinical Endocrinology, 66, 827 832.
20. Peeters, R.P., van Toor, H., Klootwijk, W. et al. (2003) Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. Journal of Clinical Endocrinology and Metabolism, 88, 2880 2888.
21. Sippel, R.S., Caron, N.R. Clark, O.H. (2007) An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World Journal of Surgery, 31, 924 933.
22. Pal, T., Vogl, F.D., Chappius, P.O. et al. (2001) Increased risk for nonmedullary thyroid cancer in the first-degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. Journal of Clinical Endocrinology and Metabolism, 86, 5307 5312.
23. Xing, M., Usadel, H., Cohen, Y. et al. (2003) Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. Cancer Research, 63, 2316 2321.
24. Brewer, C., Yeager, N. Di Cristofano, A. (2007) Thyroid-stimulating hormone-initiated proliferative signals converge in vivo on the mTOR kinase without activating AKT. Cancer Research, 67, 8002 8006.
25. Yeager, N., Klein-Szanto, A., Kimura, S. et al. (2007) Pten loss in mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. Cancer Research, 67, 959 966.
26. Repplinger, D., Bargren, A., Zhang, Y. et al. (2008) Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? Journal of Surgical Research, 150, 49 52.
27. Harach, H.R., Franssila, K.O. Wasenius, V.M. (1985) Occult papillary carcinoma of the thyroid. A 'normal' finding in Finland. A systematic autopsy study. Cancer, 56, 531 538.
28. American Cancer Society, Inc. (2008) What are the key statistics about thyroid cancer? [updated 3 October 2007] Available from http://www.cancer.org (last accessed 25 November 2008).
29. Hoelting, T., Tezelman, S., Siperstein, A.E. et al. (1993) Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC- rather than PKA-activation. Biochemical and Biophysical Research Communications, 195, 1230 1236.
30. Hoelting, T., Tezelman, S., Siperstein, A.E. et al. (1995) Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro. Thyroid, 5, 35 40.
31. Yeh, M.W., Rougier, J.P., Park, J.W. et al. (2006) Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A. Endocrine-Related Cancer, 13, 1173 1183.
32. Baldini, E., Tollen, M., Graziano, F.M. et al. (2004) Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumour cell lines. Thyroid, 14, 881 888.